EYLEA® 2mg updated SPC as approved by the Israeli MoH.
2
Papadopoulos N, Martin J, Ruan Q,
et al
. Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab. Angiogenesis. 2012;15;171-185.
